[{"_id":"556499ddfac443afdd3938cd","決算期":"2015年3月期","証券コード":"4570","会社名":"(株)免疫生物研究所【4570】","会計方式":"日本方式","決算発表日":"2015年5月13日","決算月数":"12か月","売上高":"729百万円","営業利益":"-181百万円","経常利益":"-139百万円","当期利益":"-158百万円","EPS（一株当たり利益）":"-24.20円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"398.99円","総資産":"3,138百万円","自己資本":"2,612百万円","資本金":"1,846百万円","有利子負債":"385百万円","自己資本比率":"83.2%","ROA（総資産利益率）":"-5.03%","ROE（自己資本利益率）":"-5.87%","総資産経常利益率":"-4.42%","日付":"2015-05-31T15:38:20.621Z"},{"_id":"556499ddfac443afdd3938d4","決算期":"2014年3月期","証券コード":"4570","会社名":"(株)免疫生物研究所【4570】","会計方式":"日本方式","決算発表日":"2014年5月13日","決算月数":"12か月","売上高":"670百万円","営業利益":"-107百万円","経常利益":"-99百万円","当期利益":"-114百万円","EPS（一株当たり利益）":"-17.99円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"422.69円","総資産":"3,147百万円","自己資本":"2,768百万円","資本金":"1,846百万円","有利子負債":"223百万円","自己資本比率":"88.0%","ROA（総資産利益率）":"-3.62%","ROE（自己資本利益率）":"-4.12%","総資産経常利益率":"-3.15%","日付":"2015-05-31T15:38:20.621Z"},{"_id":"556499ddfac443afdd3938dc","決算期":"---","証券コード":"4570","会社名":"(株)免疫生物研究所【4570】","会計方式":"---","決算発表日":"---","決算月数":"---","売上高":"---","営業利益":"---","経常利益":"---","当期利益":"---","EPS（一株当たり利益）":"円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"---","総資産":"---","自己資本":"---","資本金":"---","有利子負債":"---","自己資本比率":"---","ROA（総資産利益率）":"---","ROE（自己資本利益率）":"---","総資産経常利益率":"---","日付":"2015-05-31T15:38:20.621Z"}]